Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)
2017 · Journal of Clinical Oncology · 187 citations
https://doi.org/10.1200/jco.2016.71.1994
A
Alice P. Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
757
Papers
18.8K
Citations
66
h-index
216
i10-index
Alice P. Chen is an academic researcher from National Institutes of Health. The author has contributed to research in topics: PARP inhibition in cancer therapy & Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics. The author has an h-index of 66, co-authored 644 publications.
ORCID: 0000-0002-1426-853XPapers by this author
worksAdvances in using PARP inhibitors to treat cancer
2012 · BMC Medicine · 152 citations
https://doi.org/10.1186/1741-7015-10-25
Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells
2016 · Seminars in Oncology · 132 citations
https://doi.org/10.1053/j.seminoncol.2016.06.004
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy
2018 · Nature Communications · 67 citations
https://doi.org/10.1038/s41467-018-07411-7
PARP Inhibitors in Reproductive System Cancers: Current Use and Developments
2017 · Drugs · 49 citations
https://doi.org/10.1007/s40265-016-0688-7
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial
2021 · JCO Precision Oncology · 43 citations
https://doi.org/10.1200/po.20.00372
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat